Internal Medicine, Infectious Disease · Zanesville, OH
NPI
1063556074
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
945 Bethesda Dr Ste 110
Zanesville, OH, 43701
Phone (740) 450-6147
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
990 services
Medicare patients, 2024
274
Average age 72
Drug cost, 2024
$305K
550 prescriptions
Company payments, 2025
$254
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jignesh J Modi was code 99232 (hospital e&m - subsequent), 591 times for 195 patients. In total Jignesh J Modi billed 990 services in 15 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 591 | 195 | $59.78 | $35K |
| 99222 Hospital E&M - Initial | Facility | 104 | 95 | $98.82 | $10K |
| 99233 Hospital E&M - Subsequent | Facility | 83 | 66 | $89.66 | $7,442 |
| 99223 Hospital E&M - Initial | Facility | 74 | 71 | $125.55 | $9,291 |
| 99214 Office E&M - Established | Facility | 47 | 35 | $67.41 | $3,168 |
| 99213 Office E&M - Established | Facility | 26 | 19 | $50.30 | $1,308 |
| 99204 Office E&M - New | Facility | 19 | 19 | $94.19 | $1,790 |
By year: 2022 $61K for 906 services; 2023 $66K for 886 services; 2024 $71K for 990 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jignesh J Modi prescribed most often to Medicare patients was Cephalexin, with 50 prescriptions and refills. In total Jignesh J Modi wrote 550 Medicare prescriptions that cost $305K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 50 | 64 | 11 | $878 |
| Ceftriaxone Ceftriaxone Sodium | 40 | 40 | Under 11 | $2,698 |
| Vancomycin Hcl Generic | 38 | 39 | 17 | $3,851 |
| Cefepime Hcl Generic | 37 | 37 | 13 | $8,676 |
| Ertapenem Ertapenem Sodium | 36 | 36 | 16 | $16K |
| Doxycycline Hyclate Generic | 32 | 40 | 13 | $832 |
| Daptomycin Generic | 31 | 31 | Under 11 | $31K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 29 | 29 | Under 11 | $155 |
| Cefazolin Sodium Generic | 25 | 25 | Under 11 | $2,616 |
| Azithromycin Generic | 21 | 21 | Under 11 | $326 |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 17 | 17 | Under 11 | $2,342 |
| Rifampin Generic | 17 | 17 | Under 11 | $481 |
| Ethambutol Hcl Generic | 16 | 16 | Under 11 | $602 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 15 | 15 | Under 11 | $59K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 15 | 17 | Under 11 | $295 |
Brand drugs: 91 claims; generic drugs: 459 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jignesh J Modi $254 ($254 in general payments such as food, travel and fees) from 7 companies. The largest payer was Gilead Sciences, Inc. with $68.68.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.